Compliance Program. Except as disclosed in the Registration Statement or the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Samples: Icagen Inc, Icagen Inc, Marshall Edwards Inc
Compliance Program. Except as disclosed in the Registration Statement or and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA FDA, the TGA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDAFDA or TGA), ; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 3 contracts
Samples: Prana Biotechnology LTD, Prana Biotechnology LTD, Alterity Therapeutics LTD
Compliance Program. Except as disclosed in the Registration Statement or the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), except where the failure to establish and administer such noncompliance compliance program would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Curis Inc, Biocryst Pharmaceuticals Inc
Compliance Program. Except as disclosed in the Registration Statement or and the ProspectusProspectuses, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), ) except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Sales Agreement (Aeterna Zentaris Inc.), Sales Agreement (Aeterna Zentaris Inc.)
Compliance Program. Except To the extent legally required to conduct its business as disclosed described in the Registration Statement or and the Prospectus, the Company has established and administers a compliance program program, applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions function similar to those performed by the FDA), ; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 2 contracts
Samples: Market Issuance Sales Agreement (Geron Corp), Geron Corp
Compliance Program. Except as disclosed in the Registration Statement or and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA FDA, the EMA, and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDAFDA or EMA), ; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Pluristem Therapeutics Inc
Compliance Program. Except as disclosed in the Registration Statement or and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Aastrom Biosciences Inc
Compliance Program. Except as disclosed in the Registration Statement or the ProspectusProspectus (including the Incorporated Documents), the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), ; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract
Samples: Cerus Corp
Compliance Program. Except as disclosed in the Registration Statement or Statements and the Prospectus, the Company has established and administers a compliance program applicable to the Company, to assist the Company and the directors, officers and employees of the Company in complying with applicable regulatory guidelines (including, without limitation, those administered by the FDA and any other foreign, federal, state or local governmental or regulatory authority performing functions similar to those performed by the FDA), ; except where such noncompliance would not reasonably be expected to have a Material Adverse Effect.
Appears in 1 contract